Page last updated: 2024-10-19

phenylacetic acid and Malignant Carcinoid Syndrome

phenylacetic acid has been researched along with Malignant Carcinoid Syndrome in 2 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Malignant Carcinoid Syndrome: A symptom complex associated with CARCINOID TUMOR and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute CARCINOID HEART DISEASE. (Dorland, 27th ed; Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
SANDLER, M2
CLOSE, HG1
DAVIES, A1
RIMINGTON, C1

Other Studies

2 other studies available for phenylacetic acid and Malignant Carcinoid Syndrome

ArticleYear
Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptophan-secreting carcinoid tumor.
    Lancet (London, England), 1959, Sep-12, Volume: 2, Issue:7098

    Topics: 5-Hydroxytryptophan; Carcinoid Tumor; Humans; Malignant Carcinoid Syndrome; Phenylacetates

1959
Effect of phenylacetic acid on the carcinoid syndrome.
    Lancet (London, England), 1959, Sep-12, Volume: 2, Issue:7098

    Topics: Humans; Malignant Carcinoid Syndrome; Phenylacetates

1959